KRAS and intestinal cancer: This allows sustained proliferation of epithelial PDAC cells and thus tumour progression independent of overt EMT induction and contrasts with WNT- and KRAS-driven intestinal cancer subtypes, which are refractory towards aberrantly expressed SNAIL.